ReviewClinical therapeutics2013
New and emerging pharmacologic therapies for type 2 diabetes, dyslipidemia, and obesity.
James R Taylor et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewClinical therapeutics2013
James R Taylor et al.PubMed ↗Publisher ↗
No numbers read from the abstract.